GANX
Gain Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.11
−3.48%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-35.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 30, 2026 | Weidner Jeanette · officer: See Remarks | A-Award | 130,000 | $1.19 |
| Jul 17, 2026 | Melincoff Gwen A · director | A-Award | 25,000 | $1.68 |
| Jul 17, 2026 | GOLDSTEIN DOV A MD · director | A-Award | 25,000 | $1.68 |
| Jul 17, 2026 | HASLER HANS PETER · director | A-Award | 25,000 | $1.68 |
| Jul 17, 2026 | Nicaise Claude · director | A-Award | 25,000 | $1.68 |
| Jul 17, 2026 | Riley Jeffrey Scott · director | A-Award | 25,000 | $1.68 |
| Jul 17, 2026 | Islam Khalid · director | A-Award | 25,000 | $1.68 |
| Mar 26, 2026 | Fuggetta Gianluca · officer: See Remark | A-Award | 50,000 | $1.86 |
| Mar 26, 2026 | Mack Gene · director, officer: CEO, President | A-Award | 200,000 | $1.86 |
| Jun 25, 2025 | Riley Jeffrey Scott · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | GOLDSTEIN DOV A MD · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | Melincoff Gwen A · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | Islam Khalid · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | Nicaise Claude · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | RICHMAN ERIC I · director | A-Award | 15,000 | $1.79 |
| Jun 25, 2025 | HASLER HANS PETER · director | A-Award | 15,000 | $1.79 |
| Mar 21, 2025 | Fuggetta Gianluca · officer: See Remark | A-Award | 50,000 | $2.29 |
| Mar 21, 2025 | Mack Gene · director, officer: CEO, President | A-Award | 200,000 | $2.29 |
| Jan 7, 2025 | Mack Gene · director, officer: CEO, President | A-Award | 271,325 | $2.44 |
| Aug 12, 2024 | Islam Khalid · director, officer: Executive Chairman | Purchase | 50,000 | $1.00 |
| Aug 12, 2024 | Mack Gene · officer: CFO and Interim CEO | Purchase | 14,400 | $1.01 |
| Jul 1, 2024 | RICHMAN ERIC I · director | Purchase | 5,000 | $1.23 |
| Jul 1, 2024 | RICHMAN ERIC I · director | Purchase | 12,000 | $1.21 |
| Jun 26, 2024 | HASLER HANS PETER · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | Nicaise Claude · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | RICHMAN ERIC I · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | GOLDSTEIN DOV A MD · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | Riley Jeffrey Scott · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | Melincoff Gwen A · director | A-Award | 15,000 | $1.29 |
| Jun 26, 2024 | Islam Khalid · director | A-Award | 15,000 | $1.29 |
Institutional positioning
13F filings over the trailing two quarters
New 23Increased 23Reduced 21Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MARSHALL WACE, LLP | Increased | 1,923,546 | Aug 13, 2026 |
| MARSHALL WACE, LLP | Increased | 1,769,788 | May 15, 2026 |
| POTOMAC CAPITAL MANAGEMENT, INC. | Reduced | 1,008,600 | May 14, 2026 |
| Potomac Capital Management, Inc. | Reduced | 946,400 | Aug 14, 2026 |
| GSA CAPITAL PARTNERS LLP | Increased | 632,131 | Aug 6, 2026 |
| JONES FINANCIAL COMPANIES LLLP | Reduced | 631,615 | May 15, 2026 |
| JONES FINANCIAL COMPANIES LLLP | Reduced | 608,592 | Aug 14, 2026 |
| Cambridge Investment Research Advisors, Inc. | Unchanged | 568,645 | Jul 30, 2026 |
| Cambridge Investment Research Advisors, Inc. | Reduced | 566,645 | Nov 2, 2026 |
| DME CAPITAL MANAGEMENT, LP | Unchanged | 566,130 | May 15, 2026 |
| DME Capital Management, LP | Unchanged | 566,130 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 480,269 | Aug 13, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 469,567 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 453,501 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 447,342 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 30, 2026